Dosing to Rash: A Phase II Trial of the First-Line Erlotinib for Patients with Advanced Non-Small-Cell Lung Cancer an Eastern Cooperative Oncology Group Study (E3503)

ανά Brahmer, JR, Lee, JW, Traynor, AM, Hidalgo, MM, Kolesar, JM, Siegfried, JM, Guaglianone, PP, Patel, JD, Keppen, MD, Schiller, JH
Έκδοση 2013

Implementation of a standardized approach to borderline resectable pancreatic cancer in a multisite community oncology program

ανά Jonathan S. Bleeker, MD, Christopher J. Sumey, MD, Steven F. Powell, MD, Preston D. Steen, MD, Michael D. Keppen, MD, Michele Lohr, MD, Thavam Thambi-Pillai, MD, Peter Kurniali, MD, Miroslaw Mazurczak, MD, Mark M. Gitau, MD, Miran J. Blanchard, MD, Ryan K. Nowak, MD, Steven McGraw, MD, Robert Sticca, MD, Daniel Tuvin, MD, Gary Timmerman, MD
Έκδοση 2020-10-01